Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Jauset

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Research|November 8, 2019
Epigenetic <i>SMAD3</i> Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell CarcinomaRafael Ikemori, Marta Gabasa, Paula Duch, et al.
Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.
Cancer Research Communications|March 2, 2023
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and SeedingDaniel Massó-Vallés, Marie-Eve Beaulieu, Toni Jauset, et al.
Science Translational Medicine|March 22, 2019
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapyMarie-Eve Beaulieu, Toni Jauset, Daniel Massó-Vallés, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Research|November 8, 2019
Epigenetic <i>SMAD3</i> Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell CarcinomaRafael Ikemori, Marta Gabasa, Paula Duch, et al.
Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.
Cancer Research Communications|March 2, 2023
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and SeedingDaniel Massó-Vallés, Marie-Eve Beaulieu, Toni Jauset, et al.
Science Translational Medicine|March 22, 2019
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapyMarie-Eve Beaulieu, Toni Jauset, Daniel Massó-Vallés, et al.
Pageof 2